Cargando…
Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794161/ https://www.ncbi.nlm.nih.gov/pubmed/29390035 http://dx.doi.org/10.1371/journal.pone.0192424 |
_version_ | 1783297074398232576 |
---|---|
author | Yergey, Alfred L. Blank, Paul S. Cologna, Stephanie M. Backlund, Peter S. Porter, Forbes D. Darling, Allan J. |
author_facet | Yergey, Alfred L. Blank, Paul S. Cologna, Stephanie M. Backlund, Peter S. Porter, Forbes D. Darling, Allan J. |
author_sort | Yergey, Alfred L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5794161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57941612018-02-16 Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 Yergey, Alfred L. Blank, Paul S. Cologna, Stephanie M. Backlund, Peter S. Porter, Forbes D. Darling, Allan J. PLoS One Correction Public Library of Science 2018-02-01 /pmc/articles/PMC5794161/ /pubmed/29390035 http://dx.doi.org/10.1371/journal.pone.0192424 Text en © 2018 Yergey et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Yergey, Alfred L. Blank, Paul S. Cologna, Stephanie M. Backlund, Peter S. Porter, Forbes D. Darling, Allan J. Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title | Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title_full | Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title_fullStr | Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title_full_unstemmed | Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title_short | Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1 |
title_sort | correction: characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of niemann-pick disease type c1 |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794161/ https://www.ncbi.nlm.nih.gov/pubmed/29390035 http://dx.doi.org/10.1371/journal.pone.0192424 |
work_keys_str_mv | AT yergeyalfredl correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 AT blankpauls correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 AT colognastephaniem correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 AT backlundpeters correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 AT porterforbesd correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 AT darlingallanj correctioncharacterizationofhydroxypropylbetacyclodextrinsusedinthetreatmentofniemannpickdiseasetypec1 |